: iStockAnalyst.com Symbols Feed

We Expect Ailing CROs To Recover

Wed, 25 Nov 2009 14:01:23 GMT

If following the performance of contract research organizations (CROs) is like taking the temperature of the pharmaceutical industry, then drugmakers are still very much under the weather according to third-quarter results.[More...]

Indexes Do Not Tell The Tale Of Damage

Wed, 28 Oct 2009 20:27:15 GMT

First, pardon all the trading today - some days just require it. I'm already exhausted and its only 2 PM. Second, we've been saying the indexes are not reflecting the carnage seen "underneath" - my watch lists are full of names in the $500M to $5B market cap space which is my sweet spot, and it looks like September 2008 . Here is a sampling of what is really happening when you move away from McDonalds, IBM, Walmart, and Microsoft.[More...]

Contract Research Organizations Being Taken to Woodshed

Tue, 28 Oct 2008 18:42:00 GMT

It is interesting to watch the bear market come to visit every corner of this market. Up until last week the contract research organizations were one area that were holding up relatively well. Last Tuesday, ICON (ICLR) reported a stellar quarter, reaffirmed guidance ... and it has not mattered one iota as competitors in the space who have reported since have made comments that have caused everyone in the group to suffer. What I love most is how the stronger dollar is used as one of the "problems" for the US based CRO's, and ICON gets hit off that even though they are in Ireland and thus use the Euro - hence should see a tailwind from a stronger dollar/weaker Euro. But in this market everything is thrown together in one big baby in the bathwater trade. In the one week since ICON reported its stock has been pole axed from $34[More...]

Effect Of The Medicare Modernization Act on Healthcare And Allied Companies

Sat, 27 Sep 2008 21:43:00 GMT

The Healthcare Services sector can be subdivided into these sub-groups: Software: IDX Systems Corp., Cerner Corp., Eclipsys Corp., McKesson Corp.Distribution: AmerisourceBergen Inc., Cardinal Health Inc., Fisher Scientific, Henry Schien Inc., McKesson Corp., Owens and Minor Inc., Priority Healthcare Inc.Pharmacy Benefits Managers (PBM-s): Caremark RX Inc., Medco Health Systems Inc., and Express Scripts (large drug chains like Walgreen’s, CVS are excluded in this discussion).Outsourcing: Charles River Labs Inc.,[More...]

Effect of the Medicare Modernization act on Healthcare and allied companies. - Sep 12 2008 2:54PM

Fri, 12 Sep 2008 18:48:00 GMT

The Healthcare Services sector can be subdivided into these sub-groups:[More...]

Effect of the Medicare Modernization Act on Healthcare and Allied Companies. - Sep 2 2008 2:52PM

Tue, 02 Sep 2008 18:46:00 GMT

The Healthcare Services sector can be subdivided into these sub-groups:[More...]

Big Pharma Effect

Sun, 24 Aug 2008 00:39:00 GMT

I have not been the first nor will not be the last to point out the troubles of Big Pharma; however, how can you as an investor take advantage of the weak sub-sector and transfer your investments to another attractive area of Healthcare that will be reaping the benefits? In this article, I will point an attractive industry that will be benefiting from what I like to call, the Big Pharma Effect.What’s happening in Big Pharma?The patent expirations are building up and margins are getting squeezed. We’ll take a closer look at exactly what is coming off of patent. The following chart details the top twenty branded U.S. Drugs from May 2008.[More...]

Effect of the Medicare Modernization act on Healthcare and Allied companies. - Aug 22 2008 4:49PM

Fri, 22 Aug 2008 22:00:00 GMT

The Healthcare Services sector can be subdivided into these sub-groups:[More...]

Bookkeeping: Creating a CRO Basket

Wed, 13 Aug 2008 16:07:00 GMT

I've been talking about these healthcare contract research organizations (CROs) for a long time, but aside from WuXi PharmaTech (WX) have not taken the plunge - to my chagrin. With the lack of market leadership ex-healthcare, this is one sector where I ca[More...]

Periodicals Wrap-Up for Monday, August 11th

Mon, 11 Aug 2008 14:23:00 GMT

Posted By Optiondragon for Myhappytrading.com- The best social network for traders on the internet! Made BY Awesome Traders for Awesome Traders.[More...]

PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results

Mon, 10 Aug 2009 22:50:00 GMT

BOSTON, Aug. 10 /PRNewswire-FirstCall/ -- PAREXEL International Corporation today reported financial results for the fourth quarter and Fiscal Year ended June 30, 2009.
The accounting changes for ClinPhone IVR relate to Staff Accounting Bulletin (SAB) No.
The full year and fourth quarter impact of this change resulted in a reduction to consolidated service revenue of $16.9 million, reduced costs by $4.9 million, and decreased operating income by $12.0 million.

[More...]

PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2009 Earnings Release and Conference Call

Mon, 13 Jul 2009 13:56:00 GMT

PAREXEL International Corporation will release Fourth Quarter and Fiscal Year 2009 financial results on Monday, August 10, 2009 after the close of the stock market. The announcement will be available on PAREXEL's website at www.PAREXEL.com and on the PR Newswire website at www.prnewswire.com.PAREXEL will host a conference call and live webcast at 10:00 a.m. EDT on Tuesday, August 11, 2009 to discuss the results. To access the webcast, visit PAREXEL's website at www.PAREXEL.com, and click on the Investor Relations menu. This webcast will continue to be accessible for one year following the live broadcast. To participate via telephone, dial 758-4950 and ask to join PAREXEL's Fourth Quarter and Fiscal Year 2009 conference call. About the Company PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 69 locations throughout 52 countries around the world, and has over 9,400 employees. For more information about PAREXEL International visit www.parexel.com.PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of their respective business and are hereby acknowledged.Jill Baker, Vice President of Investor Relations 434-4118[More...]

Perceptive Informatics Enhances CNS and Oncology Medical Image Processing and Analysis Capabilities Through Alliance With Biospective

Thu, 09 Jul 2009 10:53:00 GMT

BOSTON, July 9 /PRNewswire-FirstCall/ -- Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation , today announced that it has enhanced its capabilities with respect to processing and analysis of medical images for central nervous system (CNS) and oncology related clinical trials through an alliance with Biospective, Inc. Through this alliance, Perceptive Informatics will use Biospective's specialized medical imaging process and analysis software to supplement its existing technology in support of independent reviews of imaging data for both exploratory and large-scale, multi-center studies.
James Paskavitz, M.D., Medical Director, Perceptive Informatics will be available at ICAD to discuss a poster presentation regarding a medical imaging methodology developed by Perceptive Informatics, which provides a new approach to monitor brain atrophy in Alzheimer's disease and potential treatment effects with the goal of accelerating decisions about Alzheimer's compounds in development.
"With CNS and oncology research growing at a fast pace, Perceptive Informatics is focused on expanding its capabilities to help clients use medical imaging as an endpoint, or biomarker, to assess efficacy and safety of new treatments in these important therapeutic areas," said Kenneth G. Faulkner, Ph.D., Vice President of Medical Imaging, Perceptive Informatics.

[More...]

Perceptive Informatics Launches the Next Level of Integration in its Industry-Leading eClinical Suite

Mon, 22 Jun 2009 09:56:00 GMT

Bringing the next level of technology integration to clinical development, Perceptive Informatics, a leading eClinical solutions provider and subsidiary of PAREXEL International Corporation , today announced that it has launched its industry-leading eClinical Suite to provide truly seamless integration and access to data across multiple technologies throughout the trial process. A unique combination of Perceptive's leading products and services, the suite is designed to realize the full potential of eClinical, yielding increased value and utility by creating an environment for more effective management and operation of clinical trials. The integrated suite features key components including the Perceptive Portal, a combined Electronic Data Capture-Integrated Voice Response solution, and a Clinical Technology Integration Platform .[More...]

Perceptive Informatics Introduces New Randomization and Trial Supply Management Reporting for Improved Data Access and Decision-Making

Thu, 18 Jun 2009 10:52:00 GMT

BOSTON, June 18 /PRNewswire-FirstCall/ -- Perceptive Informatics, the industry's leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL), today announced that it has introduced a new reporting solution as part of its ClinPhone Randomization and Trial Supply Management (RTSM) technologies, which offer validated randomization methods, automated inventory control, dispensing and titration management, and emergency code break capabilities.
The reporting solution features a Universal Report Suite to monitor trial management performance, RTSM Dashboard with trending and forecasting functionalities, and Self- Service Module with customizable search criteria for power users who are focused on in-depth data analysis.
To assist them, Perceptive Informatics offers sophisticated technologies supporting their requirements for more robust reporting and enabling faster strategic decision-making," said Todd Kole, Vice President, IVRS Business, Perceptive Informatics.

[More...]

PAREXEL International to Present at the Wachovia Equity Conference

Wed, 17 Jun 2009 09:56:00 GMT

PAREXEL International Corporation announced today it will be presenting at the Wachovia 19th Annual Mid-Year Equity Conference in Boston. James Winschel, Senior Vice President & Chief Financial Officer will be making a formal presentation on PAREXEL at 10:15 a.m. EDT on Tuesday, June 23, 2009.[More...]

PAREXEL Enhances Study Start-Up and Recruitment Capabilities With Appointment of Dr. Lars-Olof Eriksson, Formerly With Merck

Thu, 11 Jun 2009 09:56:00 GMT

PAREXEL International Corporation , a leading global biopharmaceutical services provider, has appointed Lars-Olof Eriksson, Ph.D., MS.c., to the position of Vice President of its Start-up and Accelerated Recruitment Team . Formerly a Senior Director in Clinical Research Operations specializing in patient recruitment at Merck & Co., Inc., Dr. Eriksson leads a global team of PAREXEL experts in providing a strategic, comprehensive approach to accelerate study initiation and achieve last patient in milestones for regional and international clinical trials conducted by PAREXEL for its clients.[More...]

PAREXEL Experts to Present Leading Insights at Drug Information Association 45th Annual Meeting

Wed, 03 Jun 2009 09:56:00 GMT

Experts from PAREXEL International Corporation , a leading global biopharmaceutical services provider, will address important industry issues at the Drug Information Association 45th Annual Meeting, being held from June 21 - 25, 2009 in San Diego, California. A number of PAREXEL's thought leaders will present on topics ranging from global development strategies, clinical logistics in emerging regions, clinical trial metrics, and drivers of investigator performance to conducting multinational trials, optimizing adaptive trial designs, preparing pharmacovigilance documents, and securing venture funding for drug development plans. PAREXEL experts will also discuss best practices for creating immunogenicity strategies, developing safe and effective biological medicines, and addressing regulatory challenges related to second generation therapeutic proteins.[More...]

Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials

Fri, 29 May 2009 10:54:00 GMT

BOSTON, May 29 /PRNewswire-FirstCall/ -- Perceptive Informatics, the industry's leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation , today announced the launch of a website designed to help investigators apply the new 1.1 version of RECIST (Response Evaluation Criteria In Solid Tumors) in medical imaging-based oncology trials.
Perceptive Informatics, which actively participated in the RECIST Working Group, has incorporated into its RECIST website at http://www.recist.com/ a comparison between RECIST 1.0 and 1.1, as well as instructions on how to effectively use the new criteria.
Medical imaging experts from Perceptive Informatics will be available at Booth #1881 during the American Society of Clinical Oncology (ASCO) Annual Meeting, being held today through June 2, 2009 in Orlando, Florida, to discuss application of the new RECIST 1.1 criteria.

[More...]

PAREXEL International to Present at Goldman Sachs Annual Global Healthcare Conference and the Jefferies Annual Healthcare Conference

Thu, 28 May 2009 09:55:00 GMT

PAREXEL International Corporation announced today it will be presenting at the Goldman Sachs 30th Annual Global Healthcare Conference in New York. Josef von Rickenbach, Chairman & Chief Executive Officer will be making a formal presentation on PAREXEL at 3:10 p.m. EDT on Tuesday, June 9, 2009.[More...]